Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about LSD Therapy
Recent news which mentions LSD Therapy
Can LSD Therapy Calm Anxious Dogs? First-Of-Its-Kind Study Uncovers New Possibilities
September 27, 2024
Tickers
DOGS
PETS
Tags
Market News
pets
Benzinga
From
Benzinga
Podcast: LSD 'Deserves To Reclaim Its Spot At The Lead Of The Path For Psychedelics' Says MindMed's R. Barrow
March 27, 2024
Tickers
MNMD
NEWS
Tags
Psychedelics
LSD Therapy
Interview
From
Benzinga
MindMeds Systematic Biotech Approach With New FDA Therapy Designation, 12-Week Clinical Data, Plus Expected $175M Proceeds
March 08, 2024
Tickers
MNMD
NEWS
Tags
Price Target Increases
Psychedelic/Assisted Therapies
LSD Therapy
From
Benzinga
MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials
March 07, 2024
Tickers
CMPS
MNMD
NEWS
Tags
Market News
Legal
Biotech
From
Benzinga
MindMed's 2023 Financial Results And Business Recap: Milestones Amid Rising Expenses
February 28, 2024
Tickers
MNMD
Tags
Benzinga
Biotech
Management
From
Benzinga
MindMed's 2024 Plans: Anxiety Treatment Stands, LSD Microdosing For ADHD Will Be Discontinued
January 11, 2024
Tickers
MNMD
NEWS
Tags
Benzinga
News
MNMD
From
Benzinga
Federico Fellini's LSD Journey: How It Inspired Some Of The Greatest Films Of All Time
August 23, 2023
Tags
Psychedelics
Entertainment
Market News
From
Benzinga
BetterLife Fast Tracks Its US Patent For Non-Hallucinogenic Compound And Other LSD Derivatives
June 28, 2023
Tickers
BETRF
PHRRF
Tags
Cannabis
News
PHRRF
From
Benzinga
Numinus' Clinical Arm To Lead Enrollment Site For MindMed's Phase 2b LSD Study
June 05, 2023
Tickers
CMPS
MNMD
NUMIF
Tags
Penny Stocks
Cedar Clinical Research
Market News
From
Benzinga
MindMed And FCM Holdings' Dispute Over Clinical Path Forward Deepens
May 30, 2023
Tickers
MNMD
Tags
FCM MM Holdings
Psychedelic/Assisted Therapies
Proxy fight
From
Benzinga
MindMed's LSD Study For Anxiety Treatment Enrolls And Doses 100 Participants, More Expected
May 19, 2023
Tickers
MNMD
Tags
Penny Stocks
LSD Therapy
Markets
From
Benzinga
MindMed Reports Q1 2023 Financial Results, Business Highlights, Upcoming Elections
May 05, 2023
Tickers
MNMD
Tags
Penny Stocks
Market News
Benzinga
From
Benzinga
80 Years Post-Discovery, LSD Shows Significant Potential For Major Depression In Advanced Clinical Trial
April 17, 2023
Tickers
MNMD
Tags
Management
major depressive disorder
Guidance
From
Benzinga
LSD's Impact On The Body's Cannabinoid And Microorganisms Systems, New Study Sheds Light
January 13, 2023
Tags
Cannabis
British Journal of Pharmacology
News
From
Benzinga
Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More
November 29, 2022
Tickers
AWKNF
CMND
CMPS
PSIL
Tags
Market News
Legal
Penny Stocks
From
Benzinga
MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials
November 11, 2022
Tickers
MNMD
Tags
Psychedelics
Earnings
Markets
From
Benzinga
LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress
November 04, 2022
Tickers
BLRZF
Tags
BLRZF
Markets
LSD Therapy
From
Benzinga
Psychedelics Companies And IPs: An Extended Patent Application To Protect Multiple LSD Derivatives
September 27, 2022
Tickers
BETRF
Tags
Psychedelics
Dr/ Ahmad Doroudian
Non/Hallucinogenic Psychedelic Compound
From
Benzinga
This LSD Phase 2 Clinical Trial Is Showing Positive Results For Treatment Of Generalized Anxiety
September 08, 2022
Tickers
MNMD
Tags
Biological Psychiatry
LSD Therapy
Markets
From
Benzinga
Connecting To Nature Through Psychedelics
April 17, 2022
Tickers
TECH
Tags
Tech
Benzinga
LSD
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.